Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists used genome editing to engineer a general platform to improve the safety of future human pluripotent stem cell-derived cell transplantation therapies.
[Nature Communications]
6445212 {1254621:636P8JXC} items 1 apa 0 default asc 1 150604 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-3cbb1a2c37d9d03d0f8308a0f2362abc%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22636P8JXC%22%2C%22library%22%3A%7B%22id%22%3A1254621%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Martin%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMartin%2C%20R.%20M.%2C%20Fowler%2C%20J.%20L.%2C%20Cromer%2C%20M.%20K.%2C%20Lesch%2C%20B.%20J.%2C%20Ponce%2C%20E.%2C%20Uchida%2C%20N.%2C%20Nishimura%2C%20T.%2C%20Porteus%2C%20M.%20H.%2C%20%26amp%3B%20Loh%2C%20K.%20M.%20%282020%29.%20Improving%20the%20safety%20of%20human%20pluripotent%20stem%20cell%20therapies%20using%20genome-edited%20orthogonal%20safeguards.%20%3Ci%3ENature%20Communications%3C%5C%2Fi%3E%2C%20%3Ci%3E11%3C%5C%2Fi%3E%281%29%2C%202713.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-020-16455-7%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-020-16455-7%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1254621%26amp%3Bitem_key%3D636P8JXC%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Improving%20the%20safety%20of%20human%20pluripotent%20stem%20cell%20therapies%20using%20genome-edited%20orthogonal%20safeguards%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renata%20M.%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonas%20L.%22%2C%22lastName%22%3A%22Fowler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Kyle%22%2C%22lastName%22%3A%22Cromer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20J.%22%2C%22lastName%22%3A%22Lesch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ezequiel%22%2C%22lastName%22%3A%22Ponce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nobuko%22%2C%22lastName%22%3A%22Uchida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toshinobu%22%2C%22lastName%22%3A%22Nishimura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20H.%22%2C%22lastName%22%3A%22Porteus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyle%20M.%22%2C%22lastName%22%3A%22Loh%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20their%20rapidly-expanding%20therapeutic%20potential%2C%20human%20pluripotent%20stem%20cell%20%28hPSC%29-derived%20cell%20therapies%20continue%20to%20have%20serious%20safety%20risks.%20Transplantation%20of%20hPSC-derived%20cell%20populations%20into%20preclinical%20models%20has%20generated%20teratomas%20%28tumors%20arising%20from%20undifferentiated%20hPSCs%29%2C%20unwanted%20tissues%2C%20and%20other%20types%20of%20adverse%20events.%20Mitigating%20these%20risks%20is%20important%20to%20increase%20the%20safety%20of%20such%20therapies.%20Here%20we%20use%20genome%20editing%20to%20engineer%20a%20general%20platform%20to%20improve%20the%20safety%20of%20future%20hPSC-derived%20cell%20transplantation%20therapies.%20Specifically%2C%20we%20develop%20hPSC%20lines%20bearing%20two%20drug-inducible%20safeguards%2C%20which%20have%20distinct%20functionalities%20and%20address%20separate%20safety%20concerns.%20In%20vitro%20administration%20of%20one%20small%20molecule%20depletes%20undifferentiated%20hPSCs%20%3E106-fold%2C%20thus%20preventing%20teratoma%20formation%20in%20vivo.%20Administration%20of%20a%20second%20small%20molecule%20kills%20all%20hPSC-derived%20cell-types%2C%20thus%20providing%20an%20option%20to%20eliminate%20the%20entire%20hPSC-derived%20cell%20product%20in%20vivo%20if%20adverse%20events%20arise.%20These%20orthogonal%20safety%20switches%20address%20major%20safety%20concerns%20with%20pluripotent%20cell-derived%20therapies.%22%2C%22date%22%3A%222020-06-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-020-16455-7%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41467-020-16455-7%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-09T19%3A51%3A12Z%22%7D%7D%5D%7D
Martin, R. M., Fowler, J. L., Cromer, M. K., Lesch, B. J., Ponce, E., Uchida, N., Nishimura, T., Porteus, M. H., & Loh, K. M. (2020). Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards. Nature Communications, 11(1), 2713. https://doi.org/10.1038/s41467-020-16455-7 Cite
